タンソーバイオサイエンス Company Profile

We are engaged in drug discovery and drug discovery support projects using a newly invented high-sensitivity universal GPCR activity measurement technology.

Our company applies a highly sensitive and versatile membrane protein activity measurement technology developed at the University of Tokyo's Faculty of Medicine to contribute to the enhancement of human health through the acceleration, efficiency, and expansion of opportunities in new drug development. By using our technology, it becomes possible to target all GPCRs, including many receptors that have not been viable drug discovery targets due to the lack of satisfactory evaluation systems, such as orphan GPCRs and G12/13 coupled receptors. For more details, please refer to our website.